 Clinical efficacy sucralfate treatment gastric ulcer single-blind study Japan efficacy safety dosage regimens sucralfate granules b.i.d group times q.i.d group ulcer healing patients gastric ulcer Endoscopy weeks complete healing additional weeks patients statistical analysis protocol violation b.i.d group q.i.d group patients eligible analysis rates patients b.i.d group weeks patients q.i.d group weeks weeks due patients inconvenience possibility withdrawals due treatment failures Kaplan-Meier method Wilcoxon test/logrank test calculation evaluation rates study rates weeks b.i.d group q.i.d group significant difference rates groups serious adverse effect group results b.i.d dose sucralfate granule form effective conventional dose q.i.d treatment active gastric ulcers patient compliance